PCR 📈 PCC Rokita SA - Overview
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLPCCRK00076
PCR: Chlorine, Alkali, Polyurethane, Chemicals, Cleaning, Disinfectants, Polyols
PCC Rokita SA designs, produces, and sells chemical products in Poland and internationally. It offers chlorine and alkali; polyurethane insulation systems; household chemicals and cleaning agents; washing preparations; liquid chemicals and disinfectants; vegan body and hair cleansing products; shower gels, hair shampoos, and liquid soaps; foams; and organic products, as well as polyols, naphthalene, and phosphorus derivatives. The company also provides specialty products, including anionic surfactants, alkoxylated fatty alcohols, non-ionic surfactants, synthetic and foam-forming extinguishing agents, synthetic base oils and additives, polyester polyols, chemical raw materials, polyurethane adhesives and prepolymers, polymeric polyols, and polyether polyols. Its products are used in agrochemicals, adhesives, building and construction, electronic, fire prevention, food, fuel, furniture, metallurgical, mining and drilling, oilfield, packaging, paints and coatings, personal care, pharmaceuticals, plastics, power, printing chemical, pulp and paper, refrigeration and household appliances, sports and recreation, tanning, textile, and transportation industries. The company's products are also used in coatings, adhesives, sealants, elastomers, chemical reagents, detergent, furniture, cleaning, batteries and accumulators, raw materials and intermediates, vehicle cleaning and care, and water and wastewater treatment, as well as lubricants and metalworking fluids, base oils, and additives applications. It offers its products under the Crossin, Flo, CAMOLIN, ROKO Professional, Ekoprodur, EUROPIR, #oli oli!, Flomie, SULFROKAnol, ROSULfan, ROKAnol, ROKAmer, Roteor, Rokolub, Rokester, Rokochem, Active Play, Rokanate, ipoltec, RokopolvTec, RokopoliCan, and Rokopol brands. In addition, the company provides logistics and transport services; and other services. The company was founded in 1993 and is based in Brzeg Dolny, Poland. PCC Rokita SA is a subsidiary of PCC SE. Web URL: https://www.pcc.rokita.pl
Additional Sources for PCR Stock
PCR Stock Overview
Market Cap in USD | 394m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception |
PCR Stock Ratings
Growth 5y | 56.4% |
Fundamental | 46.7% |
Dividend | 91.3% |
Rel. Strength Industry | -4811 |
Analysts | - |
Fair Price Momentum | 68.74 PLN |
Fair Price DCF | 276.32 PLN |
PCR Dividends
Dividend Yield 12m | 9.99% |
Yield on Cost 5y | 23.05% |
Annual Growth 5y | 21.02% |
Payout Consistency | 93.4% |
PCR Growth Ratios
Growth Correlation 3m | -85.4% |
Growth Correlation 12m | -68.8% |
Growth Correlation 5y | 88.8% |
CAGR 5y | 18.26% |
CAGR/Mean DD 5y | 1.27 |
Sharpe Ratio 12m | -1.34 |
Alpha | -43.08 |
Beta | 0.72 |
Volatility | 42.37% |
Current Volume | 10k |
Average Volume 20d | 3.3k |
What is the price of PCR stocks?
As of December 27, 2024, the stock is trading at PLN 67.10 with a total of 10,014 shares traded.
Over the past week, the price has changed by -2.75%, over one month by -5.89%, over three months by -17.67% and over the past year by -22.17%.
As of December 27, 2024, the stock is trading at PLN 67.10 with a total of 10,014 shares traded.
Over the past week, the price has changed by -2.75%, over one month by -5.89%, over three months by -17.67% and over the past year by -22.17%.
Is PCC Rokita SA a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, PCC Rokita SA (WAR:PCR) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.69 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PCR as of December 2024 is 68.74. This means that PCR is currently overvalued and has a potential downside of 2.44%.
Partly, yes. Based on ValueRay Fundamental Analyses, PCC Rokita SA (WAR:PCR) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.69 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PCR as of December 2024 is 68.74. This means that PCR is currently overvalued and has a potential downside of 2.44%.
Is PCR a buy, sell or hold?
PCC Rokita SA has no consensus analysts rating.
PCC Rokita SA has no consensus analysts rating.
What are the forecast for PCR stock price target?
According to ValueRays Forecast Model, PCR PCC Rokita SA will be worth about 74.8 in December 2025. The stock is currently trading at 67.10. This means that the stock has a potential upside of +11.54%.
According to ValueRays Forecast Model, PCR PCC Rokita SA will be worth about 74.8 in December 2025. The stock is currently trading at 67.10. This means that the stock has a potential upside of +11.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 85 | 26.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 74.8 | 11.5% |